comparemela.com

Page 10 - Medx Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MiMedx Group Gets FDA Warning Letter on Axiofill Classification

By Ben Glickman MiMedx Group has received a warning letter from the U.S. Food and Drug Administration related to the classification of its product Axiofill. The Marietta, Ga.-based.

MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook

The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.

MiMedx Group Gets FDA Warning Letter on Axiofill Classification

MiMedx Group Gets FDA Warning Letter on Axiofill Classification
marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.

MiMedx Group (NASDAQ:MDXG) Reaches New 1-Year High at $9 27

MiMedx Group, Inc. (NASDAQ:MDXG – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $9.27 and last traded at $9.15, with a volume of 47353 shares traded. The stock had previously closed at $9.14. Wall Street Analysts Forecast Growth A number of […]

MiMedx Group (NASDAQ:MDXG) Hits New 12-Month High at $8 71

MiMedx Group (NASDAQ:MDXG) Hits New 12-Month High at $8 71
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.